Legato Capital Management’s Adaptive Biotechnologies ADPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.12M | Sell |
182,028
-426
| -0.2% | -$4.96K | 0.25% | 106 |
|
|
2025
Q1 | $1.36M | Sell |
182,454
-2,214
| -1% | -$16.5K | 0.18% | 179 |
|
|
2024
Q4 | $1.11M | Sell |
184,668
-56,690
| -23% | -$340K | 0.14% | 265 |
|
|
2024
Q3 | $1.24M | Buy |
241,358
+31,656
| +15% | +$162K | 0.15% | 238 |
|
|
2024
Q2 | $759K | Buy |
209,702
+81,648
| +64% | +$296K | 0.1% | 330 |
|
|
2024
Q1 | $411K | Hold |
128,054
| – | – | 0.05% | 471 |
|
|
2023
Q4 | $627K | Buy |
128,054
+30,560
| +31% | +$150K | 0.08% | 364 |
|
|
2023
Q3 | $531K | Sell |
97,494
-2,543
| -3% | -$13.9K | 0.08% | 387 |
|
|
2023
Q2 | $671K | Buy |
100,037
+28,354
| +40% | +$190K | 0.09% | 352 |
|
|
2023
Q1 | $633K | Buy |
+71,683
| New | +$633K | 0.12% | 305 |
|